The FT US Pharma and Biotech Summit, originally scheduled for May 14, in New York, has been postponed - the summit will now take place on September 29, 2020 at the Convene.
We are very disappointed that it proved necessary to move the date of the event, but with the rapid increase of the Covid-19 virus across Europe and globally, together with the many travel restrictions now in place for so many of our participants, we feel that it was in the interests of all our attendees to no longer proceed as planned on May 14.
We understand how important the Summit is for all our speakers, sponsors and delegates. In the meantime, if you have any questions, or require additional information, please do not hesitate to contact us.
Thank you so much for your ongoing support of this Summit.
The 2nd edition of FT US Pharma and Biotech Summit will provide a fresh perspective on the crucial issues impacting the pharma and biotech industries today. Senior industry leaders will share their insights, ideas and expertise on topics such as the pharma pricing and politics, the future of gene editing, tracking China’s pharma growth market and the opportunities and challenges of unconventional partnerships and collaborations across the new healthcare landscape.